The company is formal, engaged in high-tech fields, with bright development prospects, strict and standardized interviews, strong professional knowledge, rich experience and high difficulty.
Xingeyuan Biotechnology Co., Ltd. is committed to applying the breakthrough single cell analysis technology to clinical detection, health management, drug research and development and other fields. The company was incorporated in June 20 18, and in May 20 18, it received tens of millions of angel rounds of financing led by Yuanhe Origin.